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Background: Peripheral ameloblastoma (PA) is a rare and unusual variant of odontogenic tumor, which was de-
scribed only in isolated case reports in literature. The objective of this study was to investigate the clinical profile, 
treatment and outcome of PA in a consecutive case series. 
Material and Methods: A total of 25 patients with histologically confirmed PA from 2001 to 2015 were retrospec-
tively reviewed in our institution. 
Results: Of the 25 patients, 22 males and 3 females were identified (male: female = 7.3:1). The average age was 
48.3 years (range 11-81 years) with lingual or palate gingival region being the most common site (76%). The 
course of disease was less than 6 months in 92.0% (23/25) of all patients (mean, 3.3 months; range, 1-12 months). 
All patients underwent complete surgical removal of the lesions, and one lesion recurrence occurred during the 
follow-up period. 
Conclusions: The clinical profile and outcome of PA from Eastern China were elucidated in this retrospective 
analysis based on a case series. Our experience may provide some insights into the differential diagnosis and 
clinical management of PA. The first choice of treatment is surgical excision, which can result in a good prognosis.




Peripheral ameloblastoma (PA) is a rare and unusual 
variant of odontogenic tumor, which accounts for 1-5% 
of all ameloblastomas. It is also known as the extraos-
seous ameloblastoma, soft tissue ameloblastoma, am-
eloblastoma of mucosal origin, or ameloblastoma of 
the gingiva (1). Refering to definition of  World Health 
Organization (4th edition, 2017), ameloblastomas were 
classified as solid/multicystic, peripheral/extraosseous, 
desmoplastic and unicystic types. Currently, the classi-
fication has been simplified and narrowed to ameloblas-
toma, unicystic ameloblastoma and peripheral/extraos-
seous types (2). PA is an exophytic growth localized 
to the soft tissues overlying the tooth-bearing areas of 
the jaws and does not invade the underlying bone. PA 
shows several histologic characteristics of an intra-os-
seous infiltrating ameloblastoma, but PA with histologi-
cally low-grade malignant features is extremely rare (1). 
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PA was first reported in the literature by Kuru in 1911 
(3), and a case report by Stanley and Krogh in 1959 was 
considered to be the first well-established case of PA 
(4). Up to now, only approximately 210 cases of PA have 
been reported in the English-language literature (1,5-
20). Hardly any consecutive case series studies on clini-
cal profile and outcome of PA are available so far, and 
this disease was described only in isolated case reports 
in literature. Therefore, a single-institution series of pa-
tients with PA in oral cavity (n = 25) were reviewed to 
investigate the clinical profile, treatment and outcome 
in a retrospective hospital-based study from China.
Material and Methods 
All the medical records of patients with pathological 
diagnoses of PA (n = 25) from January 2001 to Decem-
ber 2015 were reviewed retrospectively in a standard 
computerized database from the Shanghai Ninth Peo-
ple’s Hospital, Shanghai Jiao Tong University School 
of Medicine. The histopathologic diagnosis of all cases 
was routinely determined by an oral pathologist on duty 
from the Department of Oral Pathology, Ninth People’s 
Hospital, Shanghai Jiao Tong University School of 
Medicine. According to the WHO criteria for PA(2,21), 
reexamination and confirmation diagnosis of PA was 
performed by another oral pathologist (J. Li). Informa-
tion regarding gender, age, site of lesions, and clinical 
data was documented in detail in the records. All pa-
tients received surgical removal of the lesions with or 
without partial bone resection, and periodic follow-up 
examinations at intervals of every 6 months in the first 
2 years and at least every 12 months thereafter were rec-
ommended for patients. This study was approved by the 
local institutional review board.
Results
- Patient demographics 
Of the 25 PA patients, 22 were males and 3 were females 
with a male-to-female ratio of 7.3:1. The age of the pa-
tients ranged from 11 to 81 years with a mean of 48.3 
years. The majority of PA patients (48.0%) were in the 
fourth (n=5) and fifth (7) decade of life. There were 4 
cases in the third and sixth decade of life respectively, 
and one case occurred in pediatric period (age <18 years). 
- Course of disease 
The course of disease was less than 6 months in 92.0% 
(23/25) of patients (mean, 3.3 months; range, 1-12 
months). 
- Symptoms 
Most patients reported a gradually growing and pain-
less mass without obvious symptoms, except for one 
patient reported swelling for one month and one patient 
reported a slightly painful mass for 2 months.
- Physical examination
The majority of lesions (76.0%) were less than 2.0 cm 
(mean, 1.7 cm; range, 0.5-3.2 cm). The masses were mo-
bile, clearly palpable, and moderate to hard in hardness 
without obvious infiltration. 
- Location 
The sites of occurrence were shown in Table 1, and the 
location distribution was similar in the mandibular and 
maxillary regions. Most of the lesions (19/25) occurred 
in the lingual or palate gingival region. 
- Image examination 
Computed tomography (CT) and magnetic resonance im-
aging (MRI) revealed a well-demarcated circular mass. 
However, the tumor was not enhanced on contrast CT, 
and a short signal was observed in T1 and T2-weighted 
MRI images. CT and MRI usually demonstrated no in-
vasion to the jaws and adjacent muscles. Representative 
image examination of one case is shown in Figure 1. 
- Laboratory examination 
Routine laboratory tests were performed in all patients, 
and all the results were within the normal reference ranges. 
- Preoperative clinical diagnosis 
Preoperative clinical diagnosis was difficult to make, 
especially in the absence of biopsy or fine needle aspira-
tion cytology. The differential diagnoses included epu-
lis (n = 8), fibroma (n = 5), oral ulcer (n = 3), lymphoma 
(n = 5), and oral squamous cell carcinoma (n = 3). 
- Treatment 
All patients underwent complete surgical removal of the 
lesions under local (1% lidocaine) or general anesthesia. 
All specimens were processed for routine histopathologic 
examination. For small lesions, conservative supra peri-
osteal surgical excision was performed with adequate 
disease-free margins. While for large lesions, incisional 
biopsies were performed when differential diagnosis in-
cluded malignant lesions before operation. Partial bone 
was resected if cuplike or saucerized bone involvement 
was detected during the operation. Primary closure and 
wound healing were achieved in all patients.
Site No. of cases Proportion
Maxillary  12 48%
Anterior region 7 28%
Premolar region 2 8%
Molar region 3 12%
Mandible 13 52%
Anterior region 1 4%
Premolar region 5 20%
Molar region 7 28%
Table 1. Sites of occurrence of the 25 intraoral PA cases.
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- Gross specimen
The lesions were mostly described as a firm to slightly 
spongy mass of pink to pinkish grey. The cut surface 
may contain minute cystic spaces filled with clear, pale-
yellow fluid. As occasional areas of dystrophic calci-
fication were very small, they were not disclosed by 
cutting through the specimen or on a radiograph of the 
operation specimen. The size of the masses ranged from 
0.5*0.3cm to 3.2*3.0cm with a mean of 1.5*1.4 cm. Re-
presentative gross specimen of one case is shown in 
Figure 2 (A-D). 
- Pathologic diagnosis
The postoperative pathologic diagnosis was PA in all 
patients. Most of the epithelial islands exhibited pali-
sading of columnar basal cells, and stellate reticulum 
was seldom conspicuous. Bone or periosteum was not 
involved in the pathology of PA patients. Representative 
histopathology of one case is shown in Figure 2 (E, F). 
- Follow-up 
The follow-up period of the patients ranged from 3 to 
180 months with a mean of 61 months. During the fol-
low-up period, only one case recurred. The recurrent 
Fig. 1. Representative image examination (CT images, MRI images, panoramic X-ray 
and dental film) of one case of peripheral ameloblastoma.
Fig. 2. Representative clinical and pathological exami-
nation of one case of peripheral ameloblastoma (PA). (A) 
Front view of intraoral PA located on lingual gingiva of 
theretromolar region. (B) No cauliflower-like hyperplasia 
in the mucosa. (C) Gross specimen showed a firm to slightly 
spongy mass of pinkish grey. (D) No bone involvement. (E, 
F) Representative histopathology of this case of PA. Epithe-
lial islands exhibited palisading of columnar basal cells and 
satellite reticulum was seldom conspicuous (Hematoxylin-
Eosin staining). Magnification, E, ×100, F . ×200.
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PA developed from the general site of the original le-
sion, and the reason was speculated to be incomplete 
removal rather than aggressiveness. Overall, all patients 
had good quality of life. 
Discussion 
In the English-language literature, there were few case 
series of the demographics and clinical data of PA be-
cause of its low incidence rate. This disease was de-
scribed only in isolated case reports in literature. Ac-
cording to the clinical data of literature review (1,4), PA 
occurs more frequently in males than in females, with 
a male-to-female ratio of 1.8:1. However, the male-to-
female ratio is as high as 7.3:1 with an obvious male-
predominant in our case series. This was probably due 
to the ethnic population and geographic difference. PA 
can occur at all ages (rang, 9-92 years) but most fre-
quently in adults aged 40 to 60 years. It is very rare in 
children, and the earliest age of occurrence was repor-
ted in a 9-year-old male (1). In our series of 25 patients, 
the majority of PA patients (64.0%) were in the fourth 
to sixth decade of life (range, 11-81 years), with a mean 
age of 48.3 years. The youngest patient in our series was 
an 11-year-old female with the lesion in the left anterior 
maxillary region.
PA is frequently an incidental finding during a routine 
dental examination. As such, it is a challenge for clini-
cians to make a correct diagnosis at its first presenta-
tion. Imaging modalities, such as CT and MRI, may be 
helpful for the diagnosis as they can sometimes clearly 
demarcate the lesions. This is because in most cases, the 
lesions are located near the bone and within the normal 
tissue boundaries. Bone involvement known as cupping 
or saucerization is rare in PA patients. Saucerization re-
fers to a depression made from the pressure of the tumor 
on bone. However, it is usually mild with no neoplastic 
invasion or marrow infiltration (1). The dense fibrous 
tissue of the gingiva and periosteum and the cortical 
plate of the alveolar process may be responsible for an 
effective barrier to the infiltration of PA. The biological 
behavior of PA is consistent with that of a hamartoma 
or persistent hyperplasia rather than that of a neoplasm. 
The clinical manifestations of PA, such as the course of 
disease, lesion growth and symptoms, are not specific 
for PA, making it difficult to distinguish between PA 
and some other lesions, such as epulis, fibroma, squa-
mous cell carcinoma, and lymphoma (1,13). For intraoral 
lesions, ultrasonic examination was rarely performed, 
and the lesions could be incorrectly diagnosed as epulis 
or periapical fistula. Based on a relatively large num-
ber of case series, some experience was summarized as 
following. The diagnosis of PA may be considered if: 
(i) the mass grows slowly without pain and trismus;(ii) 
no cauliflower-like change in the superficial mucosa or 
less mucosal lesion than submucosal mass; and (iii) CT 
or MRI shows clear boundary between bone and medi-
alpterygoid muscle, uniform density and less enhanced 
images. In these cases, fine needle aspiration or biopsy 
is strongly recommended to prevent unnecessary surgi-
cal intervention. 
For small lesions, conservative supra periosteal surgi-
cal excision with an adequate disease-free margin is 
recommended even in the case of no confirmed diag-
nosis. While for large lesions, incisional biopsies were 
performed when differential diagnosis included malig-
nant lesions before operation. Partial bone was resected 
if cuplike or saucerized bone involvement was detected 
during the operation. Continuous follow up is necessary 
due to the possibility of late recurrence or malignant 
changes.
In summary, the clinical profile and outcome of PA 
from Eastern China were elucidated in this retrospec-
tive analysis based on a case series. Our experience may 
provide some insights into the differential diagnosis and 
clinical management of PA. The first choice of treat-
ment is surgical excision, which can result in a good 
prognosis.  
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